Acorah Software Products - Accounts Production 16.4.675 false true true 30 June 2024 1 July 2023 false 1 July 2024 30 June 2025 30 June 2025 09623164 Mr Kiran-Jai Sharma Miss Diwa Sharma Mr Kiran-Jai Sharma true iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 09623164 2024-06-30 09623164 2025-06-30 09623164 2024-07-01 2025-06-30 09623164 frs-core:Non-currentFinancialInstruments 2025-06-30 09623164 frs-core:ComputerEquipment 2024-07-01 2025-06-30 09623164 frs-core:FurnitureFittings 2024-07-01 2025-06-30 09623164 frs-core:InvestmentPropertyIncludedWithinPPE 2025-06-30 09623164 frs-core:InvestmentPropertyIncludedWithinPPE 2024-07-01 2025-06-30 09623164 frs-core:InvestmentPropertyIncludedWithinPPE 2024-06-30 09623164 frs-core:PlantMachinery 2025-06-30 09623164 frs-core:PlantMachinery 2024-07-01 2025-06-30 09623164 frs-core:PlantMachinery 2024-06-30 09623164 frs-core:ShareCapital 2025-06-30 09623164 frs-core:RetainedEarningsAccumulatedLosses 2025-06-30 09623164 frs-bus:PrivateLimitedCompanyLtd 2024-07-01 2025-06-30 09623164 frs-bus:FilletedAccounts 2024-07-01 2025-06-30 09623164 frs-bus:SmallEntities 2024-07-01 2025-06-30 09623164 frs-bus:AuditExempt-NoAccountantsReport 2024-07-01 2025-06-30 09623164 frs-bus:SmallCompaniesRegimeForAccounts 2024-07-01 2025-06-30 09623164 1 2024-07-01 2025-06-30 09623164 frs-core:FurtherSpecificReserve1ComponentTotalEquity 2024-07-01 2025-06-30 09623164 frs-core:FurtherSpecificReserve1ComponentTotalEquity 2024-06-30 09623164 frs-core:FurtherSpecificReserve1ComponentTotalEquity 2025-06-30 09623164 frs-bus:Director1 2024-07-01 2025-06-30 09623164 frs-bus:Director2 2024-07-01 2025-06-30 09623164 frs-countries:EnglandWales 2024-07-01 2025-06-30 09623164 2023-06-30 09623164 2024-06-30 09623164 2023-07-01 2024-06-30 09623164 frs-core:Non-currentFinancialInstruments 2024-06-30 09623164 frs-core:ShareCapital 2024-06-30 09623164 frs-core:RetainedEarningsAccumulatedLosses 2024-06-30 09623164 frs-core:FurtherSpecificReserve1ComponentTotalEquity 2024-06-30
Registered number: 09623164
KS Medici Ltd
Unaudited Financial Statements
For The Year Ended 30 June 2025
Optimise Accountants Ltd
Office 15 Bramley House 2a
Bramley Road
Long Eaton
Nottinghamshire
NG10 3SX
KS Medici Ltd
Contents
Contents

| Page
--- | ---
Balance Sheet | 1—2
Notes to the Financial Statements | 3—5

Page 1
KS Medici Ltd
Balance Sheet
As At 30 June 2025
Balance Sheet
Registered number: 09623164

| 2025 | 2024
--- | --- | ---
| Notes | £ | £ | £ | £
FIXED ASSETS
Tangible Assets | 4 |  | 2,114,562 |  | 2,078,201
|  |  | 2,114,562 |  | 2,078,201
CURRENT ASSETS
Debtors | 5 | 11,548 |  | 16,669 |
Cash at bank and in hand |  | 3,042 |  | 7,712 |
|  | 14,590 |  | 24,381 |
Creditors: Amounts Falling Due Within One Year | 6 | (752,752 ) |  | (762,660 ) |
NET CURRENT ASSETS (LIABILITIES) |  |  | (738,162 ) |  | (738,279 )
TOTAL ASSETS LESS CURRENT LIABILITIES |  |  | 1,376,400 |  | 1,339,922
Creditors: Amounts Falling Due After More Than One Year | 7 |  | (1,375,700 ) |  | (1,381,772 )
PROVISIONS FOR LIABILITIES
Deferred Taxation |  |  | (61,491 ) |  | (54,344 )
NET LIABILITIES |  |  | (60,791 ) |  | (96,194 )
CAPITAL AND RESERVES
Called up share capital | 9 |  | 100 |  | 100
Fair value reserve | 10 |  | 262,146 |  | 195,788
Profit and Loss Account |  |  | (323,037 ) |  | (292,082 )
SHAREHOLDERS' FUNDS |  |  | (60,791) |  | (96,194)

Page 1
Page 2
KS Medici Ltd
Balance Sheet (continued)
As At 30 June 2025
For the year ending 30 June 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board

Mr Kiran-Jai Sharma Director
02/09/2025

The notes on pages 3 to 5 form part of these financial statements.
Page 2
Page 3
KS Medici Ltd
Notes to the Financial Statements
For The Year Ended 30 June 2025
Notes to the Financial Statements
1. General Information
KS Medici Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 09623164 . The registered office is Office 15 Bramley House 2a, Bramley Road, Long Eaton, Nottinghamshire, NG10 3SX.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Going Concern Disclosure
The directors have not identified any material uncertainties related to events or conditions that may cast significant doubt about the company's ability to continue as a going concern.
2.3. Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.
Sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods has transferred to the buyer. This is usually at the point that the customer has signed for the delivery of the goods.
Rendering of services
Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
2.4. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:

Plant & Machinery | 20% reducing balance basis
Fixtures & Fittings | 20% reducing balance basis
Computer Equipment | 20% reducing balance basis

2.5. Investment Properties
Investment properties are measured at fair value determined annually and adjusted if necessary for any difference in the nature, location or condition of the specific asset. The fair value of property was obtained from an online property resource company and has not been based on a valuation by an independent valuer with a professional qualification.
2.6. Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences. Deferred tax assets are generally recognised for all deductible temporary differences to the extent that it is probable that taxable profits will be available against which those deductible timing differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.
Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred tax liabilities are presented within provisions for liabilities and deferred tax assets within debtors. The measurement of deferred tax liabilities and assets reflect the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities.
Current and deferred tax are recognised in profit or loss for the year, except when they relate to items that are recognised in other comprehensive income or directly in equity, in which case current and deferred tax are recognised in other comprehensive income or directly in equity respectively.
Page 3
Page 4
KS Medici Ltd
Notes to the Financial Statements (continued)
For The Year Ended 30 June 2025
3. Average Number of Employees
Average number of employees, including directors, during the year was: 2 (2024: 2)
2 2
4. Tangible Assets

| Investment Properties | Plant & Machinery etc. | Total
--- | --- | --- | ---
| £ | £ | £
Cost or Valuation
As at 1 July 2024 | 2,073,586 | 9,640 | 2,083,226
Additions | - | 464 | 464
Disposals | (652 ) | (258 ) | (910 )
Revaluation | 37,616 | - | 37,616
As at 30 June 2025 | 2,110,550 | 9,846 | 2,120,396
Depreciation
As at 1 July 2024 | - | 5,025 | 5,025
Provided during the period | - | 957 | 957
Disposals | - | (148 ) | (148 )
As at 30 June 2025 | - | 5,834 | 5,834
Net Book Value
As at 30 June 2025 | 2,110,550 | 4,012 | 2,114,562
As at 1 July 2024 | 2,073,586 | 4,615 | 2,078,201

5. Debtors

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Due within one year
Other debtors | 11,548 |  | 16,669

6. Creditors: Amounts Falling Due Within One Year

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Other creditors | 752,752 |  | 762,660

7. Creditors: Amounts Falling Due After More Than One Year

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Bank loans | 1,353,941 |  | 1,354,457
Other creditors | 21,759 |  | 27,315
| 1,375,700 |  | 1,381,772

8. Secured Creditors
Of the creditors the following amounts are secured.

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Bank loans and overdrafts | 1,353,941 |  | 1,354,457

Page 4
Page 5
KS Medici Ltd
Notes to the Financial Statements (continued)
For The Year Ended 30 June 2025
9. Share Capital

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Allotted, Called up and fully paid | 100 |  | 100

10. Reserves

| Fair Value Reserve
--- | ---
| £
As at 1 July 2024 | 195,788
Transfer to profit and loss | 66,358
As at 30 June 2025 | 262,146

11. Ultimate Controlling Party
The company's ultimate controlling party is Mr Kiran-Jai Sharma by virtue of his ownership of 100% of the issued share capital in the company.
Page 5